publication venue for
- Hydroxychloroquine-Chloroquine, QT-Prolongation, and Major Adverse Cardiac Events: A Meta-analysis and Scoping Review. 58:742-755. 2024
- Development of Clinical Pharmacy Key Performance Indicators for Hospital Pharmacists Using a Modified Delphi Approach. 49:656-669. 2015
- Calcium Channel Blocker–Clarithromycin Drug Interaction Did Not Increase the Risk of Nonvertebral Fracture. 49:185-188. 2015
- Integrating Electronic Health Records in the Delivery of Optimized Anticoagulation Therapy. 49:125-126. 2015
- Effect of Anticholinergic Medications on Falls, Fracture Risk, and Bone Mineral Density Over a 10-Year Period. 48:954-961. 2014
- An Interdisciplinary Memory Clinic. 48:785-795. 2014
- Medication Reconciliation During Internal Hospital Transfer and Impact of Computerized Prescriber Order Entry. 44:1887-1895. 2010
- Hypokalemia Following Polyethylene Glycol–Based Bowel Preparation for Colonoscopy in Older Hospitalized Patients with Significant Comorbidities. 44:466-470. 2010
- Vancomycin-Associated Uterine Contractions and Bleeding. 44:594-595. 2010
- Interventions to Improve Medication Reconciliation in Primary Care. 43:1667-1675. 2009
- Medication Reconciliation at Hospital Discharge: Evaluating Discrepancies. 42:1373-1379. 2008
- Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum. 42:979-988. 2008
- Drug Reimbursement Policies in Canada—Need for Improved Access to Critical Therapies. 42:869-873. 2008
- Intramuscular Methotrexate-Induced Aseptic Meningitis. 41:1906-1911. 2007
- Increased Adverse Drug Reactions to Antimicrobials and Anticonvulsants in Patients with HIV Infection. 40:1594-1601. 2006
- Does Celecoxib Potentiate the Anticoagulant Effect of Warfarin? A Randomized, Double-Blind, Controlled Trial. 40:1241-1247. 2006
- Are Brand-Name and Generic Warfarin Interchangeable? Multiple N-of-1 Randomized, Crossover Trials. 39:1188-1193. 2005
- Influence of Warfarin on Symptoms of Fatigue: Findings of a Randomized Trial. 39:840-842. 2005
- Effects of Natural Health Products on Blood Pressure. 39:712-720. 2005
- Comment: Treatment of Heparin-Induced Thrombocytopenia. 36:1483-1484. 2002
- Safety of Benzodiazepines in Newborns. 36:1150-1155. 2002
- Inhibition of Warfarin Activity by Ribavirin. 36:72-74. 2002
- Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): A Randomized Trial Design of the Effect of a Community Pharmacist Intervention Program on Serum Cholesterol Risk. 33:910-919. 1999
- Contemporary Utilization of Digoxin in Patients with Atrial Fibrillation. 33:289-293. 1999
- The Effect of ICU Sedation Guidelines and Pharmacist Interventions on Clinical Outcomes and Drug Cost. 31:689-695. 1997
- Opioid-induced muscle activity - Comment. 30:1042-1043. 1996
- Experience in The Development of a Postmarketing Surveillance Network: The Pharmacy Medication Monitoring Program. 29:1208-1213. 1995
- Significance of Plasma Thiothixene Concentrations. 29:789-790. 1995
- Comment: Attribution of Blame in Drug-Induced Thrombocytopenia. 25:874-875. 1991